Therapy Areas: Cardiovascular
Kancera and Recardio sign letter of intent for licensing agreement
7 March 2025 - Kancera AB (Nasdaq First North Premier Growth Market:KAN), a developer of anti-inflammatory drugs in the field of cardiovascular diseases, said on Friday that it has signed a letter of ...
Novo Nordisk launches NovoCare Pharmacy to reduce Wegovy costs and expand access
5 March 2025 - Danish pharmaceutical company Novo Nordisk A/S (CPH:NOVO-B) (NYSE:NVO) on Wednesday introduced NovoCare Pharmacy, a direct-to-patient delivery service offering all dose strengths of Weg...
Redx Pharma reports positive Phase 1 results for RXC008 in fibrostenotic Crohn's disease
24 February 2025 - Clinical-stage, small molecule biotechnology company Redx Pharma (JPJ: REDX) announced on Monday that it presented positive Phase 1 trial results for RXC008, a potential first-in-cl...
Hims & Hers acquires Trybe Labs to expand at-home testing capabilities
19 February 2025 - Health and wellness platform Hims & Hers Health Inc (NYSE: HIMS) announced on Wednesday that it has acquired at-home lab testing facility Sigmund NJ LLC, marketed as Trybe Labs,...
TriNetX and Fujitsu form joint venture to enhance clinical research in Japan
12 February 2025 - TriNetX, a US-based provider of real-world data and real-world evidence solutions, and Japanese ICT company Fujitsu (TYO:6702) announced on Wednesday the launch of a joint venture, ...
Novartis to acquire Anthos Therapeutics in USD925m deal to expand cardiovascular pipeline
11 February 2025 - Swiss pharmaceutical company Novartis Pharma AG (SIX:NOVN) (NYSE:NVS) announced on Tuesday that it has signed an agreement to acquire Anthos Therapeutics, a clinical-stage biopharma...